Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
This study is currently recruiting participants.
Study NCT00323583 Information provided by Seattle Cancer Treatment and Wellness Center
First Received: May 5, 2006 Last Updated: May 7, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Adenocarincoma of Pancreas
Stage III Pancreatic Cancer
Stage IVA Pancreatic Cancer
Stage IVB Pancreatic Cancer
Additional conditions recognized in this trial
Pancreatic Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Site
Pancreatic Diseases
Interventions listed in this trial
paclitaxel
oxaliplatin
leucovorin
5-fluorouracil
glutathione
calcium and magnesium
Chemotherapy
Chemoprotection
Additional drug interventions recognized in this trial
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Seattle Cancer Treatment and Wellness Center
Back to top of Main Content